We are live on ! Find out more
GCIA

Gabelli & Co Investment Advisers Portfolio holdings

AUM $674M
1-Year Est. Return 64.52%
This Fund
S&P 500
This Quarter Est. Return
+14.57%
1 Year Est. Return
+64.52%
3 Year Est. Return
+233.32%
5 Year Est. Return
+564.3%
10 Year Est. Return
+5,313.55%
AUM
$651M
AUM Growth
-$10.4M
Cap. Flow
-$40.4M
Cap. Flow %
-6.21%
Top 10 Hldgs %
33.34%
Holding
313
New
62
Increased
51
Reduced
31
Closed
48

Top Buys

Rank Stock Value
1
BPMC
Blueprint Medicines
BPMC
+$19M
2
SKX
Skechers
SKX
+$16.5M
3
SWTX
SpringWorks Therapeutics
SWTX
+$12.6M
4
WBA
Walgreens Boots Alliance
WBA
+$9.26M
5
DNB
Dun & Bradstreet
DNB
+$7.98M

Top Sells

Rank Stock Value
1
ITCI
Intra-Cellular Therapies Inc.
ITCI
+$26.7M
2
FNA
Paragon 28, Inc.
FNA
+$18.3M
3
BECN
Beacon Roofing Supply, Inc.
BECN
+$18M
4
DFS
Discover Financial Services
DFS
+$16.7M
5
DESP
Despegar.com
DESP
+$12.8M

Sector Composition

Rank Sector Weight
1 Healthcare 17.22%
2 Communication Services 15.3%
3 Technology 11.49%
4 Industrials 8.49%
5 Consumer Discretionary 8.47%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
HES
1
DELISTED
Hess
HES
$31.3M 4.81%
226,233
-2,000
-0.9% -$270K
K
2
DELISTED
Kellanova
K
$29.3M 4.5%
368,643
+20,300
+6% +$1.66M
BPMC
3
DELISTED
Blueprint Medicines
BPMC
$23.5M 3.61%
+183,374
New +$19M
FYBR
4
DELISTED
Frontier Communications
FYBR
$23M 3.53%
631,119
+42,419
+7% +$1.54M
AMED
5
DELISTED
Amedisys
AMED
$22.1M 3.39%
224,443
+26,948
+14% +$2.55M
JNPR
6
DELISTED
Juniper Networks
JNPR
$18.6M 2.86%
466,130
+14,000
+3% +$502K
SKX
7
DELISTED
Skechers
SKX
$18.2M 2.79%
+287,814
New +$16.5M
CHX
8
DELISTED
ChampionX
CHX
$17.4M 2.67%
700,626
+188,668
+37% +$4.75M
SPR
9
DELISTED
Spirit AeroSystems
SPR
$17.4M 2.67%
456,065
-3,392
-0.7% -$122K
GDV icon
10
Gabelli Dividend & Income Trust
GDV
$2.64B
$16.3M 2.5%
626,000
– –
ALE
11
DELISTED
Allete
ALE
$16.1M 2.48%
251,700
+13,950
+6% +$906K
GDL
12
GDL Fund
GDL
$92.3M
$15.4M 2.37%
1,846,636
– –
SWTX
13
DELISTED
SpringWorks Therapeutics
SWTX
$15.2M 2.34%
324,350
+282,100
+668% +$12.6M
TGI
14
DELISTED
Triumph Group
TGI
$15.2M 2.33%
588,705
+100,400
+21% +$2.56M
FOX icon
15
Fox Class B
FOX
$21.9B
$12.7M 1.95%
246,011
+10,000
+4% +$487K
DNB
16
DELISTED
Dun & Bradstreet
DNB
$11.8M 1.81%
1,296,535
+891,585
+220% +$7.98M
WBA
17
DELISTED
Walgreens Boots Alliance
WBA
$11.8M 1.81%
1,026,585
+831,635
+427% +$9.26M
PARA
18
DELISTED
Paramount Global Class B
PARA
$9.85M 1.51%
763,843
+27,250
+4% +$319K
GLU
19
Gabelli Utility & Income Trust
GLU
$116M
$8.43M 1.29%
486,810
– –
AVDX
20
DELISTED
AvidXchange
AVDX
$8.31M 1.28%
+849,207
New +$7.66M
ANSS
21
DELISTED
Ansys
ANSS
$7.69M 1.18%
21,886
-8,250
-27% -$2.7M
FL
22
DELISTED
Foot Locker
FL
$7.66M 1.18%
+312,550
New +$5.68M
FARO
23
DELISTED
Faro Technologies
FARO
$7.62M 1.17%
+173,500
New +$6.35M
TXNM
24
TXNM Energy Inc
TXNM
$5.93B
$6.97M 1.07%
+123,836
New +$6.74M
VIGL
25
DELISTED
Vigil Neuroscience
VIGL
$6.88M 1.06%
+864,950
New +$3.88M
1
2 3 4 5

Similar funds

RCM
Redwood Capital Management New York $674M AUM 99.78% 1-Year Est. Return
DPC
Dream Peak Capital Hong Kong $675M AUM
BFA
Blueprint Financial Advisors Greensboto, North Carolina $675M AUM 24.91% 1-Year Est. Return
CCM
Corsair Capital Management New York $673M AUM 109.99% 1-Year Est. Return
CHCM
Columbus Hill Capital Management Short Hills, New Jersey $673M AUM 24.63% 1-Year Est. Return
JC
JBF Capital Aspen, Colorado $676M AUM 24.74% 1-Year Est. Return
NI
Noked Israel Ramat Hasharon, Israel $677M AUM 69.37% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return

Gabelli & Co Investment Advisers's Q2 2025 Portfolio in Review

As of Q2 2025, Gabelli & Co Investment Advisers held 313 positions worth $651M, down 1.6% from $662M the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Gabelli & Co Investment Advisers withdrew a net $40.4M in Q2 2025, closing 48 positions and reducing 31 holdings. Its most notable exit was Intra-Cellular Therapies Inc., an estimated $26.7M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 16% a quarter earlier, followed by Communication Services and Technology.

Against the trend, Gabelli & Co Investment Advisers opened a new position in Blueprint Medicines worth $23.5M.

  • Gabelli & Co Investment Advisers's largest Q2 2025 buy was Blueprint Medicines: 183,374 shares worth $23.5M.
  • Gabelli & Co Investment Advisers added most to SpringWorks Therapeutics in Q2 2025, an estimated $12.6M increase.
  • Gabelli & Co Investment Advisers's biggest Q2 2025 reduction was Albertsons Companies, cutting an estimated $4.03M.
  • Gabelli & Co Investment Advisers fully exited Intra-Cellular Therapies Inc. in Q2 2025, selling an estimated $26.7M.
  • Gabelli & Co Investment Advisers's ten largest holdings make up 33% of its $651M portfolio in Q2 2025.
  • Gabelli & Co Investment Advisers opened 62 new positions and closed 48 in Q2 2025.
  • Gabelli & Co Investment Advisers's portfolio value fell 1.6% quarter-over-quarter to $651M.

Based on Gabelli & Co Investment Advisers's 13F filing for Q2 2025, filed 13 Aug 2025.